{
    "root": "313093fe-89fb-4ca8-973c-f36175bb47df",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "DOTAREM",
    "value": "20250314",
    "ingredients": [
        {
            "name": "WATER",
            "code": "059QF0KO0R"
        },
        {
            "name": "GADOTERATE MEGLUMINE",
            "code": "L0ND3981AG"
        }
    ],
    "indications": "dotarem gadolinium-based contrast agent indicated intravenous magnetic resonance imaging ( mri ) brain ( intracranial ) , spine associated tissues adult pediatric patients ( including term neonates ) detect visualize areas disruption blood brain barrier ( bbb ) and/or abnormal vascularity .",
    "contraindications": "adult pediatric patients : recommended dose dotarem 0.2 ml/kg ( 0.1 mmol/kg ) body weight administered intravenous bolus injection flow rate approximately 2 ml/second adults 1 - 2 ml/second pediatric patients ( including term neonates ) . dose delivered manual power injection .",
    "warningsAndPrecautions": "dotarem injection clear , colorless yellow solution containing 0.5 mmol/ml gadoterate meglumine . supplied vials prefilled syringes . dotarem injection supplied 10 ml vials containing 5 ml 10 ml solution , 20 ml vials containing 15 ml 20 ml solution . single dose vial closed rubber stopper sealed aluminum cap contents sterile . vials individually packaged shrink wrapped package 10 , following configurations : 5 ml glass vial ( ndc 67684-2000-0 ) 10 ml glass vial ( ndc 67684-2000-1 ) 15 ml glass vial ( ndc 67684-2000-2 ) 20 ml glass vial ( ndc 67684-2000-3 ) vials also packaged box 10 , following configurations : 5 ml glass vial ( ndc 67684-2001-0 ) 10 ml glass vial ( ndc 67684-2001-1 ) 15 ml glass vial ( ndc 67684-2001-2 ) 20 ml glass vial ( ndc 67684-2001-3 ) dotarem injection supplied 20 ml plastic pre-filled syringes containing 10 ml , 15 ml 20 ml solution syringe sealed rubber closures contents sterile . syringes , including plunger rod , packaged box 10 , following configurations : 10 ml plastic pre-filled syringe ( ndc 67684-3001-1 ) 15 ml plastic pre-filled syringe ( ndc 67684-3001-2 ) 20 ml plastic pre-filled syringe ( ndc 67684-3001-3 ) storage store 25°c ( 77°f ) ; excursions permitted 15°c 30°c ( 59°f 86°f ) [ usp , controlled room temperature ( crt ) ] . pre-filled syringes must frozen . frozen syringes discarded . solidification occur vial exposure cold , bring dotarem room temperature . allowed stand room temperature minimum 90 minutes , dotarem return clear , colorless yellow solution . , examine product assure solids dissolved container closure damaged . discard vial solids persist .",
    "adverseReactions": "history clinically important hypersensitivity dotarem [ ( 5.2 ) ] .",
    "indications_original": "DOTAREM is a gadolinium-based contrast agent indicated for intravenous use with magnetic resonance imaging (MRI) in brain (intracranial), spine and associated tissues in adult and pediatric patients (including term neonates) to detect and visualize areas with disruption of the blood brain barrier (BBB) and/or abnormal vascularity.",
    "contraindications_original": "Adult and pediatric patients: The recommended dose of DOTAREM is 0.2 mL/kg (0.1 mmol/kg) body weight administered as an intravenous bolus injection at a flow rate of approximately 2 mL/second for adults and 1 - 2 mL/second for pediatric patients (including term neonates). The dose is delivered by manual or power injection.",
    "warningsAndPrecautions_original": "DOTAREM Injection is a clear, colorless to yellow solution containing 0.5 mmol/mL of gadoterate meglumine. It is supplied in vials and prefilled syringes.\n                  \n                  \n                     DOTAREM Injection is supplied in 10 mL vials containing 5 mL or 10 mL of solution, in 20 mL vials containing 15 mL or 20 mL of solution.\n                  \n                  \n                  Each single dose vial is closed with a rubber stopper and sealed with an aluminum cap and the contents are sterile. Vials are individually packaged in a shrink wrapped package of 10, in the following configurations:\n                  \n                  5 mL in glass vial (NDC 67684-2000-0)\n                  10 mL in glass vial (NDC 67684-2000-1)\n                  15 mL in glass vial (NDC 67684-2000-2)\n                  20 mL in glass vial (NDC 67684-2000-3)\n                  \n                  Vials are also packaged in a box of 10, in the following configurations:\n                  \n                  5 mL in glass vial (NDC 67684-2001-0)\n                  10 mL in glass vial (NDC 67684-2001-1)\n                  15 mL in glass vial (NDC 67684-2001-2)\n                  20 mL in glass vial (NDC 67684-2001-3)\n                  \n                  \n                     DOTAREM Injection is supplied in 20 mL plastic pre-filled syringes containing 10 mL, 15 mL or 20 mL of solution\n                  \n                  \n                  Each syringe is sealed with rubber closures and the contents are sterile. Syringes, including plunger rod, are packaged in a box of 10, in the following configurations:\n                  10 mL in plastic pre-filled syringe (NDC 67684-3001-1) 15 mL in plastic pre-filled syringe (NDC 67684-3001-2) 20 mL in plastic pre-filled syringe (NDC 67684-3001-3)\n                  \n                     Storage\n                  \n                  Store at 25°C (77°F); excursions permitted to 15°C to 30°C (59°F to 86°F) [see USP, Controlled Room Temperature (CRT)].\n                  Pre-filled syringes must not be frozen. Frozen syringes should be discarded.\n                  Should solidification occur in the vial because of exposure to the cold, bring DOTAREM to room temperature before use. If allowed to stand at room temperature for a minimum of 90 minutes, DOTAREM should return to a clear, colorless to yellow solution. Before use, examine the product to assure that all solids are dissolved and that the container and closure have not been damaged. Discard the vial if solids persist.",
    "adverseReactions_original": "History of clinically important hypersensitivity reactions to DOTAREM  [see Warnings and Precautions (5.2)] ."
}